PMC · DOI:10.3389/fmolb.2026.1794468·February 2, 2026
Editorial: Advancements in immune heterogeneity in inflammatory diseases and cancer: new targets, mechanisms, and strategies
Yongqiang Zhang, Yuqin Tang
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases2
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Single-cell and spatial transcriptomics · Immune cells in cancer